Page 10 - Double Blind News Today

Three lawmakers are looking to pass the bill in the state this year.

The long-acting glatiramer acetate therapy GA Depot was found to ease disability in patients with relapsing forms of MS in a Phase 3 trial.

While balancing multiple high-profile gigs, the multi-instrumentalist and A-list sideman Dean Fertita has taken a step forward in his solo career with his first solo outing in over a decade. The anticipated Tropical Gothclub, released in late 2022, is his first record since 2009’s Hello=Fire, and features a mixture of harmonized leads, propulsive energy, and more trippy, dreamy moments.

Data from Certa Therapeutics' Phase 2 clinical trial with development candidate FT011 demonstrates clinically meaningful improvements for more than 60 percent of patients with scleroderma after 12 weeks of treatment; Clinically meaningful improvements were reported in CRISS (the key composite endpoint for systemic sclerosis) lung function, SHAQ-DI and Physician Global Assessment; The trial results also showed FT011 to be safe and well tolerated in this patient population; FT011 is a novel, f...

/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced two presentations of NKTR-255 at the 64th American Society of Hematology (ASH) Annual...

Hyderabad (Telangana) [India], November 29 (ANI/PRNewswire): Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969 (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms. This study is unique as it covers both the IBS-Diarrhea and IBS-Constipation groups with larger number of subjects. Irritable bowel syndrome (IBS) is one of the most common...

So polished and pristine that the only pity is that it didn’t come sooner.

Aptabios Isuzinaxib (APX-115) proves its effect on a key kidney function marker in a Phase 2 clinical study in patients with diabetes and chronic kidney...

A special Sunday episode of FBI has the team tracking a missing child while the Scola-Nina relationship faces a huge challenge.

/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2022. Cash and investments in...